Opportunity

SAM #NCI-DCTD-27-0001

NCI Chemotherapeutic Agents Repository Operations and Sample Management

Buyer

NCI

Posted

November 17, 2026

Respond By

December 02, 2026

Identifier

NCI-DCTD-27-0001

NAICS

541990

The National Cancer Institute is seeking capable sources to operate its Chemotherapeutic Agents Repository and manage research-compound samples for investigators. - Government buyer: Department of Health and Human Services, National Institutes of Health, National Cancer Institute (NCI), Division of Cancer Treatment and Diagnosis, Developmental Therapeutics Program, Drug Synthesis and Chemistry Branch. - Requirement: Operate and maintain the NCI Chemotherapeutic Agents Repository, supporting small molecules and purified natural products from acquisition and registration through storage, analysis, and distribution. - Repository scale: Approximately 500,000–600,000 samples; about 5,000 single agents acquired and evaluated annually; approximately 400 samples received, registered, and shipped monthly; and about 2,500 samples weighed and shipped monthly. - Services include compound receipt, inventory and database management, current and archival records, sample reacquisition, investigator information support, authorized disposal, and shipping. Compounds may also need to be arrayed in 96-well and 384-well plates and undergo analytical testing. - Notable requirements: Controlled ambient, refrigerated, -15 to -20 °C, and -70 to -80 °C storage; limited inert-atmosphere, light-protected, and humidity-controlled storage; and emergency storage backup for five days. Analytical turnaround may not exceed 10 working days; urgent data or report requests must be handled within 30–90 minutes during business hours, with other requests within 24–48 hours. - OEMs and vendors: No OEMs or vendors are identified by name. This is market research, not a solicitation; small businesses are encouraged to respond.

Description

This Sources Sought Notice is issued as a means of conducting market research to identify any/all parties, to include large and small businesses, having an interest in and the resources to support the requirements for Registration, Storage and Distribution of Chemicals and Drugs for Pre-Clinical Discovery Evaluation and Development. This is NOT a solicitation for proposals, proposal abstracts, or quotations. 

Interested parties are expected to review this notice and the draft Statement of Work (SOW) to familiarize themselves with the requirement of this project; failure to do so will be at your firm’s own risk.

The Drug Synthesis and Chemistry Branch (DSCB) of the Developmental Therapeutics Program (DTP) of the Division of Cancer Treatment and Diagnosis (DCTD) of the National Cancer Institute (NCI) is seeking support services to operate and maintain the National Cancer Institute’s Chemotherapeutic Agents Repository (NCI-CAR).  This acquisition is responsible for providing an informational interface with NCI and external investigators that are submitting or requesting research compounds; for updating of the chemical database which includes chemical, inventory, receiving and shipping information; systematic file and record keeping of both current and archival information related to repository activities; and reacquisition of samples for continued chemical and biological studies.  Towards this goal, the Program acquires and evaluates about 5,000 single agents each year in anticancer assays.  In addition, research samples are provided to the general research community both in vialed and plated format.  NCI-CAR is responsible for receiving, storage and distribution services along with curating an inventory of approximately 500,000 - 600,000 individual samples and associated chemical, inventory and distribution data.  Approximately 400 samples are received monthly, registered and shipped to NCI testing facilities; an additional 2,500 samples are weighed monthly from inventory and shipped to research investigators both in the U.S. (including NCI) and foreign countries.

The purpose of this Sources Sought Notice is to identify all potentially capable, interested sources. We encourage you to respond to this Sources Sought Notice; particularly if you are a small business. All Small Business Set-Aside categories will be considered.

As a result of this Sources Sought notice, the NCI may issue a Request for Proposal (RFP).  THERE IS NO SOLICITATION AVAILABLE AT THIS TIME.  However, should such a requirement materialize, no basis for claim against the NCI shall arise as a result of a response to this Sources Sought Notice or the NCI’s use of such information as either part of our evaluation process or in developing specification for any subsequent requirement.

View original listing